Alnylam’s Liver Cancer RNAi Program Enters the Clinic
RNAi leader advances its first systemically delivered program—a liposomal formulation of two siRNA molecules—into the clinic.
RNAi leader advances its first systemically delivered program—a liposomal formulation of two siRNA molecules—into the clinic.